The rising level of obesity in the general population is mirrored in patients with type 1 diabetes (T1DM), and this may be further exacerbated by extra weight gain as a result of more intensive insulin regimens employed with the laudable aim of tightening glycaemic control and preventing ...
Afrezza, a rapid-acting inhaled insulin, is FDA-approved for use before meals for both type 1 and type 2 diabetes. The drug peaks in your blood in about 15-20 minutes and it clears your body in 2-3 hours. It must be used along with long-acting insulin in people with type 1 diabete...
Type 1 diabetes mellitus is predominantly a disease of the young, usually developing before 20 years of age. Overall, type I DM makes up approximately 15% of all cases ofdiabetes. It develops in approximately 1 in 600 children and is one of the most common chronic diseases in children. The...
The author reflects on the applications of non-insulin therapies for type I diabetes. Topics discussed include treatment of type I diabetes with the help of sulfonylureas (SFUs), metformin and thiazolidinediones (TZDs), introduction of new non-insulin agents for treatment including glucagon-like pept...
Arising from: M. Nakayama et al. Nature 435, 220–223 (2005) and S. C. Kent et al. Nature 435, 224–228 (2005); D. A. Hafler et al. reply Spontaneous type 1 diabetes occurs when the autoimmune destruction of pancreatic β-islet cells prevents production
Data processing and analysis for "Determining the optimal timing for insulin injection to minimize glucose level variability after a meal in ideal conditions" - a research project for the IB Standard Level Mathematics Analysis and Approaches course inspired by my type 1 diabetes. python data-science...
To evaluate the treatment indications, effectiveness and adverse events of continuous subcutaneous insulin infusion (CSII) in adults with type 1 diabetes mellitus using data from a registry at the University Medical Centre Ljubljana, Ljubljana, Slovenia. The registry included patients with type 1 diabet...
A. More insulin release helps sugar level rise. B. people drinking diet soda hardly absorb sugar. C. Type 2 diabetes mainly results from artificial sweeteners. D. Consuming artificial sweeteners might cause health problems.4. What does the passage mainly talk about? A. The potential of ...
on Advanced Technologies & Treatments for Diabetesin Paris, France, was said to be the first randomized trial to compare the safety and effectiveness of CGM with vs without confirmatory finger-stick blood glucose monitoring (BGM) to make therapeutic decisions in people with type 1 diabetes. ...
At the beginning of the study, there were no significant differences between groups in C-peptide level, hemoglobin A 1c level, age, or duration of diabetes. Mean blood glucose level during the study for the computer group was 121 mg/dl (6.7 m M), which was significantly lower (p <0.01...